Can aplastic anemia patients survive long-term with blood transfusions?

Aplastic anemia, also known as aplasia, is a genetic disorder caused by the body's lack of normal hemoglobin. Patients with aplastic anemia may survive long-term with blood transfusions, but those with severe disease may not survive long-term even with transfusions. The specific analysis is as follows:

1. Long-term survival is possible

Aplastic anemia is a hereditary condition resulting from insufficient production of normal hemoglobin in the body. Blood transfusions can supply components such as red blood cells, hemoglobin, and iron, improving both the quantity and quality of red blood cells in the patient's bloodstream. This enhances oxygen delivery and alleviates symptoms of aplastic anemia. Therefore, patients with this condition can maintain normal life functions through regular, long-term blood transfusions.

2. Long-term survival may not be possible

In patients with severe aplastic anemia, bone marrow function is significantly impaired, making it impossible to produce sufficient blood cells effectively. These patients rely on blood transfusions to sustain life. However, transfusions do not address the root problem—loss of bone marrow function. Over time, the condition progressively worsens, further reducing the body’s ability to regenerate blood cells. As a result, patients require increasingly frequent and larger volumes of transfusions. Long-term transfusion therapy can lead to various complications, including infections and allergic reactions, which negatively affect both quality of life and life expectancy. Therefore, patients with severe disease may not survive long-term despite ongoing transfusions.

In summary, while blood transfusion is essential in treating aplastic anemia, it must be combined with other therapeutic approaches and conducted under medical supervision.